{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:10:46Z","timestamp":1769742646436,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Ga(III) can mimic Fe(III) in the biological system due to its similarities in charge and ionic radius to those of Fe(III) and can exhibit antimicrobial activity by disrupting the acquisition and metabolism of Fe in bacterial cells. For example, Ga(NO3)3 has been proven to be effective in treating chronic lung infections by Pseudomonas aeruginosa (P. aeruginosa) in cystic fibrosis patients in a recent phase II clinical trial. However, Ga(NO3)3 is an ionic compound that can hydrolyze to form insoluble hydroxides at physiological pH, which not only reduces its bioavailability but also causes potential renal toxicity when it is used as a systemic drug. Although complexion with suitable chelating agents has offered a varying degree of success in alleviating the hydrolysis of Ga(III), the use of nanotechnology to deliver this metallic ion should constitute an ultimate solution to all the above-mentioned problems. Thus far, the development of Ga-based nanomaterials as metalloantibiotics is an underexploited area of research. We have developed two different synthetic routes for the preparation of biocompatible Ga2(HPO4)3 NPs and shown that both the PVP- or PEG-coated Ga2(HPO4)3 NPs exhibit potent antimicrobial activity against P. aeruginosa. More importantly, such polymer-coated NPs do not show any sign of Ga-resistant phenotype development after 30 passes, in sharp contrast to Ga(NO3)3, which can rapidly develop Ga-resistant phenotypes of P. aeruginosa, indicating the potential of using Ga2(HPO4)3 NPs a new antimicrobial agent in place of Ga(NO3)3.<\/jats:p>","DOI":"10.3390\/antibiotics12111578","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:50:42Z","timestamp":1698670242000},"page":"1578","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of Biocompatible Ga2(HPO4)3 Nanoparticles as an Antimicrobial Agent with Improved Ga Resistance Development Profile against Pseudomonas aeruginosa"],"prefix":"10.3390","volume":"12","author":[{"given":"Huda","family":"Alamri","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44240, USA"},{"name":"Department of Chemistry, College of Science, University of Jeddah, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44240, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songping D.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44240, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1473-3099(05)70086-4","article-title":"Lack of development of new antimicrobial drugs: A potential serious threat to public health","volume":"5","author":"Norrby","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.48.7.2431-2436.2004","article-title":"Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002","volume":"48","author":"Flamm","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.01330-08","article-title":"Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice","volume":"53","author":"DeLeon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: A rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrd3975","article-title":"Platforms for Antibiotic Discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1039\/C9SC06460E","article-title":"Metal Complexes as a Promising Source for New Antibiotics","volume":"11","author":"Frei","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","article-title":"Metals to Combat Antimicrobial Resistance","volume":"7","author":"Frei","year":"2023","journal-title":"Nat. Rev. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI30783","article-title":"The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity","volume":"117","author":"Kaneko","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.coph.2013.07.001","article-title":"Gallium-based anti-infectives: Targeting microbial iron-uptake mechanisms","volume":"13","author":"Kelson","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e00481-17","DOI":"10.1128\/AAC.00481-17","article-title":"A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity","volume":"61","author":"Richter","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eaat7520","DOI":"10.1126\/scitranslmed.aat7520","article-title":"Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections","volume":"10","author":"Goss","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.micro.54.1.881","article-title":"Iron metabolism in pathogenic bacteria","volume":"54","author":"Ratledge","year":"2000","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00775-008-0376-5","article-title":"Ga3+ as a mechanistic probe in Fe3+ transport: Characterization of Ga3+ interaction with FbpA","volume":"13","author":"Weaver","year":"2008","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.bbamcr.2016.04.027","article-title":"Gallium and its competing roles with iron in biological systems","volume":"1863","author":"Chitambar","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_15","first-page":"665","article-title":"Mechanisms of Therapeutic Activity for Gallium","volume":"50","author":"Bernstein","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2217\/fmb.14.3","article-title":"Promises and failures of gallium as an antibacterial agent","volume":"9","author":"Minandri","year":"2014","journal-title":"Future Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/MBD.2000.33","article-title":"Chemistry and Pharmacokinetics Of Gallium Maltolate, A Compound With High Oral Gallium Bioavailability","volume":"7","author":"Bernstein","year":"2000","journal-title":"Met.-Based Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16761","DOI":"10.1073\/pnas.0808608105","article-title":"The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent","volume":"105","author":"Banin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ica.2012.06.003","article-title":"Gallium complexes as new promising metallodrug candidates","volume":"393","author":"Lessa","year":"2012","journal-title":"Inorg. Chim. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1039\/C5CS00041F","article-title":"Inorganic nanoparticles engineered to attack bacteria","volume":"44","author":"Miller","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/wnan.1282","article-title":"Nanoparticle approaches against bacterial infections","volume":"6","author":"Gao","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/anie.201713177","article-title":"KCa(H2O)2[Fe(III) (CN)6]H2O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus","volume":"57","author":"Wang","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_23","first-page":"225","article-title":"Conductometric Titrations","volume":"2","author":"Kolthoff","year":"1930","journal-title":"Ind. Eng. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/ac60137a020","article-title":"Improved Conductometric Titration of Weak Bases","volume":"30","author":"McCurdy","year":"1958","journal-title":"Anal. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1556-276X-9-17","article-title":"Investigation on the role of the molecular weight of polyvinyl pyrrolidone in the shape control of high-yield silver nanospheres and nanowires","volume":"9","author":"Song","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17883","DOI":"10.1039\/C5DT02964C","article-title":"Polyvinylpyrrolidone (PVP) in nanoparticle synthesis","volume":"44","author":"Koczkur","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9381","DOI":"10.1021\/acs.jmedchem.1c00656","article-title":"Lipophilic Ga Complex with Broad-Spectrum Antimicrobial Activity and the Ability to Overcome Gallium Resistance in both Pseudomonas aeruginosa and Staphylococcus aureus","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11051-019-4617-z","article-title":"Attachment efficiency of gold nanoparticles by Gram-positive and Gram-negative bacterial strains governed by surface charges","volume":"21","author":"Pajerski","year":"2019","journal-title":"J. Nanoparticle Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.3390\/ijms13066639","article-title":"Synthesis and characterization of polyethylene glycol mediated silver nanoparticles by the green method","volume":"13","author":"Shameli","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10856-016-5777-3","article-title":"Biocompatible nano-gallium\/hydroxyapatite nanocomposite with antimicrobial activity","volume":"27","author":"Kurtjak","year":"2016","journal-title":"J. Mater. Sci. Mater. Med."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/11\/1578\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:13:59Z","timestamp":1760130839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/11\/1578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["antibiotics12111578"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12111578","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}